← Back to search

Hepatx

Replacing organ transplant with an infusion

Y CombinatorSummer 2018ActiveHealthcareTherapeuticsBiotech

What they do

Problem

Patients with chronic liver disease rely on scarce, invasive organ transplants with significant risks and limited availability.

Solution

It develops regenerative medicine infusion therapies to repair or regenerate damaged liver tissue as an alternative to transplantation.

Who it's for

Hospitals and clinicians treating patients with chronic liver disease who would otherwise require liver transplantation.

Founders

Eric Schuur
Founder/CEO

Company timeline

Similar startups